Home » Topics » BioWorld Science

BioWorld Science
RSS

Targeting NuRD for derepression of fetal hemoglobin in hemoglobinopathies

Aug. 22, 2019

PDX model allows study of hepatitis B virus in hepatocellular carcinoma

Aug. 22, 2019

Anti-RSV agent ziresovir demonstrates promising preclinical profile

Aug. 22, 2019

First patient enrolled in observational study of children and adolescents with Dravet syndrome

Aug. 21, 2019

Mersana Therapeutics initiates expansion portion of phase I trial of XMT-1536

Aug. 21, 2019

Phase III NEPTUNE study does not meet primary endpoint in patients with high TMB

Aug. 21, 2019

New cyclin-dependent kinase 4/6 inhibitors identified at Beta Pharma

Aug. 21, 2019

ST Pharm presents new antivirals

Aug. 21, 2019

Blastocyst-like embryonic structure grown from stem cells

Aug. 21, 2019

Tau imagining agents patented by AC Immune, Life Molecular Imaging

Aug. 21, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...